REDUCTION OF ORAL BIOAVAILABILITY OF LIGNOCAINE BY INDUCTION OF FIRST PASS METABOLISM IN EPILEPTIC PATIENTSPERUCCA E; RICHENS E.1979; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1979; VOL. 8; NO 1; PP. 21-31; BIBL. 2 P.Article

CIRCADIAN RHYTHMS IN CELL MIGRATION IN VITRO, AND ITS EFFECT ON ANTIGEN-INDUCED MIGRATION INHIBITIONRICHENS E; BROWN KA; COLLINS AJ et al.1975; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1975; VOL. 19; NO 2; PP. 343-346; BIBL. 9 REF.Article

The effect of adjuvants on immune function in the multi-low-dose streptozotocin model of murine diabetesRICHENS, E. R; BEHBEHANI, K.International journal of tissue reactions. 1988, Vol 10, Num 4, pp 207-216, issn 0250-0868Article

Type 2 diabetes in Arab patients in KuwaitRICHENS, E. R; ABDELLA, N; JAYYAB, A. K et al.Diabetic medicine. 1988, Vol 5, Num 3, pp 231-234, issn 0742-3071Article

Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in OmanAL-MAINI, M. H; EL-AGEB, E. M; AL-WAHAIBI, S. S et al.Rheumatology international (Berlin. Print). 2003, Vol 23, Num 4, pp 186-191, issn 0172-8172, 6 p.Article

Tribal and geographical variations of lupus in the Sultanate of Oman: a hospital-based studyAL MAINI, M. H; EL-AGEB, El-Nour; AL-SHUKAILY, A. K et al.Rheumatology international (Berlin. Print). 2002, Vol 21, Num 4, pp 141-145, issn 0172-8172Article

HLA associations in an arab type 1 diabetic populationBEHBEHANI, K; RICHENS, E. R; ABDELLA, N et al.Disease markers. 1987, Vol 5, Num 3, pp 165-169, issn 0278-0240Article

Clinical features of Behçet's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies?EL-AGEB, E. M; AL-MAINI, M. H; AL-SHUKAILY, A. K et al.Rheumatology international (Berlin. Print). 2002, Vol 21, Num 5, pp 176-181, issn 0172-8172Article